Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R David Anderson

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
International Journal of Cardiology|July 26, 2018
Maladaptive left ventricular remodeling in women: An analysis from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction studyOmeed Elboudwarej, Janet Wei, Navid Darouian, et al.
Frontiers in Cardiovascular Medicine|June 16, 2023
Autoimmune rheumatic diseases in women with coronary microvascular dysfunction: a report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) projectMelanie T Chen, Joseph Chang, Ashley S Manchanda, et al.
JACC. Cardiovascular Interventions|June 23, 2012
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) studyJanet Wei, Puja K Mehta, B Delia Johnson, et al.
Journal of the American Heart Association|February 18, 2020
Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) StudyHaider Aldiwani, Melody Zaya, Nissi Suppogu, et al.
American Heart Journal|December 3, 2014
Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cellsEmerson C Perin, Michael Murphy, John P Cooke, et al.
International Journal of Cardiology|February 11, 2020
Resting coronary velocity and myocardial performance in women with impaired coronary flow reserve: Results from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) studyNissi Suppogu, Janet Wei, Michael D Nelson, et al.
American Heart Journal|December 30, 2019
Design, methodology and baseline characteristics of the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD)Odayme Quesada, Ahmed AlBadri, Janet Wei, et al.
The Journal of Invasive Cardiology|January 7, 2022
Transcatheter Aortic Valve Implantation With or Without Predilation: A Meta-AnalysisFederico Conrotto, Fabrizio D'Ascenzo, Luca Franchin, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 12, 2014
Clinical pharmacogenetics implementation: approaches, successes, and challengesKristin W Weitzel, Amanda R Elsey, Taimour Y Langaee, et al.
European Heart Journal|November 29, 2015
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserveC Noel Bairey Merz, Eileen M Handberg, Chrisandra L Shufelt, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
International Journal of Cardiology|July 26, 2018
Maladaptive left ventricular remodeling in women: An analysis from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction studyOmeed Elboudwarej, Janet Wei, Navid Darouian, et al.
Frontiers in Cardiovascular Medicine|June 16, 2023
Autoimmune rheumatic diseases in women with coronary microvascular dysfunction: a report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) projectMelanie T Chen, Joseph Chang, Ashley S Manchanda, et al.
JACC. Cardiovascular Interventions|June 23, 2012
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) studyJanet Wei, Puja K Mehta, B Delia Johnson, et al.
Journal of the American Heart Association|February 18, 2020
Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) StudyHaider Aldiwani, Melody Zaya, Nissi Suppogu, et al.
American Heart Journal|December 3, 2014
Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cellsEmerson C Perin, Michael Murphy, John P Cooke, et al.
International Journal of Cardiology|February 11, 2020
Resting coronary velocity and myocardial performance in women with impaired coronary flow reserve: Results from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) studyNissi Suppogu, Janet Wei, Michael D Nelson, et al.
American Heart Journal|December 30, 2019
Design, methodology and baseline characteristics of the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD)Odayme Quesada, Ahmed AlBadri, Janet Wei, et al.
The Journal of Invasive Cardiology|January 7, 2022
Transcatheter Aortic Valve Implantation With or Without Predilation: A Meta-AnalysisFederico Conrotto, Fabrizio D'Ascenzo, Luca Franchin, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 12, 2014
Clinical pharmacogenetics implementation: approaches, successes, and challengesKristin W Weitzel, Amanda R Elsey, Taimour Y Langaee, et al.
European Heart Journal|November 29, 2015
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserveC Noel Bairey Merz, Eileen M Handberg, Chrisandra L Shufelt, et al.
Pageof 12